Comprehensive management of peritoneal surface malignancy using cytoreductive surgery and perioperative intraperitoneal chemotherapy: The Washington Cancer Institute approach

Expert Opinion on Pharmacotherapy

Volumn 10, Issue 12, 2009, Pages 1965-1977

  Sugarbaker, Paul H ^a  

^a WASHINGTON CANCER INSTITUTE   (United States)

Author keywords

Colon cancer; CT; Cytoreductive surgery; Gastric cancer; Intraperitoneal chemotherapy; Ovarian cancer; Peritoneal carcinomatosis; Peritoneal mesothelioma; Peritonectomy; Pseudomyxoma peritonei

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; FLUOROURACIL; GEMCITABINE; MELPHALAN; MITOMYCIN C; OXALIPLATIN; PACLITAXEL;

APPENDIX TUMOR; AREA UNDER THE CURVE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARCINOMATOSIS; CLINICAL TRIAL; COLORECTAL CANCER; CYTOREDUCTIVE SURGERY; CYTOTOXICITY; DIGESTIVE SYSTEM CANCER; DRUG BLOOD LEVEL; DRUG MEGADOSE; DRUG PENETRATION; ELECTROSURGERY; GASTROINTESTINAL CARCINOMA; HUMAN; HYPERTHERMIC THERAPY; INTERMETHOD COMPARISON; METASTASIS; MONOTHERAPY; OVARY CANCER; PERIOPERATIVE PERIOD; PERITONEAL CAVITY; PERITONECTOMY; PERITONEUM CANCER; PERITONEUM MESOTHELIOMA; PERITONEUM PSEUDOMYXOMA; PLEURA CAVITY; PLEURA MESOTHELIOMA; REVIEW; STOMACH CANCER; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CARCINOMA; COMBINED MODALITY THERAPY; ELECTROSURGERY; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; HYPERTHERMIA, INDUCED; MALE; MESOTHELIOMA; PERIOPERATIVE CARE; PERITONEAL LAVAGE; PERITONEAL NEOPLASMS; PERITONEUM; PSEUDOMYXOMA PERITONEI;

EID: 68149160035     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656560903044974     Document Type: Review

References (37)

1. Sugarbaker PH, Editor, Peritoneal Carcinomatosis: Principles of Management. Kluwer Academic Publishers, Boston, USA 1996
2. Sugarbaker PH, Ronnett BM, Archer A, et al. Pseudomyxoma peritonei syndrome. Adv Surg 1997;30:233-280
3. Yu W, Whang I, Young C, et al. Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer: results of a prospective randomized trial. World J Surg 2001;25(8):985-990 (Pubitemid 32747644)
4. Sugarbaker PH, Yu W, Yonemura Y. Gastrectomy, peritonectomy and perioperative intraperitoneal chemotherapy: The evolution of treatment strategies for advanced gastric cancer. Semin Surg Oncol 2003;21:233-248 (Pubitemid 37521721)
5. Shen P, Hawksworth J, Lovato J, et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol 2004;11(2):178-186 (Pubitemid 40486793)
6. Pestieau SR, Sugarbaker PH. Treatment of primary colon cancer with peritoneal carcinomatosis: a comparison of concomitant versus delayed management. Dis Colon Rectum 2000;43:1341-1348
7. Sugarbaker PH, Yan TD, Stuart OA, Yoo D. Comprehensive management of diffuse malignant peritoneal mesothelioma. Eur J Surg Oncol 2006;32(6):686-691 (Pubitemid 44063999)
8. Sugarbaker PH, Mora JT, Carmignani P, et al. Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy. Oncologist 2005;10(2):112-122 (Pubitemid 40261950)
9. Mohamed F, Marchettini P, Stuart OA, Sugarbaker PH. Pharmacokinetics and tissue distribution of intraperitoneal paclitaxel with different carrier solutions. Cancer Chemother Pharmacol 2003;52(5):405-410 (Pubitemid 37363614)
10. Ozols RF, Locker GY, Doroshow JH. Pharmacokinetics of adriamycin and tissue penetration in murine ovarian cancer. Cancer Res 1979;39:3209-3214 (Pubitemid 9231829)
11. Los G, Mutsaers PHA, van der Vijgh WJF, et al. Direct diffusion of cis-Diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy. Cancer Res 1989;49:3380-3384 (Pubitemid 19162154)
12. Sugarbaker PH. Management of Peritoneal Surface Malignancy Using Intraperitoneal Chemotherapy and Cytoreductive Surgery. A Manual for Physicians and Nurses, Third Edition. The Ludann Company, Grand Rapids, Michigan, USA 1998
13. Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995;221:29-42
14. Sugarbaker PH, Averbach AM, Jacquet P, et al. A simplified approach to hyperthermic intraoperative intraperitoneal chemotherapy (HIIC) using a self-retaining retractor. In: Sugarbaker PH, editor, Peritoneal Carcinomatosis: Principles of Management, Kluwer Academic Publishers, Boston, USA, 1996. p. 415-421
15. Zoetmulder FAN, Sugarbaker PH. Patterns of failure following treatment of pseudomyxoma peritonei of appendiceal origin. Eur J Cancer 1996;32A(10):1727- 1733
16. Jacquet P, Averbach A, Stephens AD, et al. Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-fluorouracil: pharmacokinetic studies. Oncology 1998;55(2):130-138 (Pubitemid 28052257)
17. Jacquet P, Averbach AM, Stuart OA, et al. Hyperthermic intraperitoneal doxorubicin: Pharmacokinetics, metabolism, and tissue distribution in a rat model. Cancer Chemother Pharmacol 1998;41(2):147-154 (Pubitemid 28096269)
18. Sugarbaker PH. An instrument to provide containment of intraoperative intraperitoneal chemotherapy with optimized distribution. J Surg Oncol 2005;92(2):142-146
19. Urano M, Kuroda M, Nishimura Y. Invited review. For the clinical application of thermochemotherapy given at mild temperatures. Int J Hyperthermia 1999;15(2):79-107 (Pubitemid 29149801)
20. Herman TS. Temperature Dependence of Adriamycin, cis- Diamminedichloroplatinum, Bleomycin, and 1,3-Bis(2-chloroethyl)-1-nitrosourea Cytotoxicity in Vitro. Cancer Res 1983;43(2):517-520
21. Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 2004;22(16):3284-3292 (Pubitemid 41103684)
22. van der Speeten K, Stuart OA, Sugarbaker PH. Pharmacokinetics and pharmacodynamics of perioperative cancer chemotherapy in peritoneal surface malignancy. Cancer J 2009;15(3):216-224
23. Stuart OA, Stephens AD, Welch L, Sugarbaker PH. Safety monitoring of the coliseum technique for heated intraoperative intraperitoneal chemotherapy with mitomycin C. Ann Surg Oncol 2002;9(2):186-191 (Pubitemid 34259706)
24. Schmid K, Boettcher MI, Pelz JOW, et al. Investigations on safety of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with Mitomycin C. Eur J Surg Oncol 2006;32(10):1222-1225 (Pubitemid 44774394)
25. Gonzalez-Moreno S, Sugarbaker PH. Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding. Br J Surg 2004;91(3):304-311 (Pubitemid 38375769)
26. Sugarbaker PH. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999;6(8):727-731
27. Sugarbaker PH. New standard of care for appendiceal epithelial malignancies and pseudomyxoma peritonei syndrome. Lancet Oncol 2006;7(1):69-76
28. Yan TD, Black D, Savady R, Sugarbaker PH. A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol 2007;14(2):484-492 (Pubitemid 46175292)
29. Yan TD, Black D, Savady R, Sugarbaker PH. Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol 2006;24(24):4011-4019 (Pubitemid 46630752)
30. Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003;21(20):3737-3743
31. Elias D, Lefevre JH, Chevalier J, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 2008;27(5):681-685
32. Jacquet P, Sugarbaker PH. Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res 1996;15(1):49-58 (Pubitemid 26130826)
33. Elias D, Goere D, Di Pietrantonio D, et al. Results of systematic second-look surgery in patients at high risk of developing colorectal peritoneal carcinomatosis. Ann Surg 2008;247(3):445-450
34. Yan TD, Black D, Sugarbaker PH, et al. A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol 2007;14(10):2702-2713 (Pubitemid 47460649)
35. Richards WG, Zellos L, Bueno R, et al. Phase I to II study of pleurectomy/ decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma. J Clin Oncol 2006;24(10):1561-1567 (Pubitemid 46638779)
36. Sugarbaker PH. Peritoneum as the first line of defense in carcinomatosis. J Surg Oncol 2007;95(2):93-96 (Pubitemid 46238975)
37. Stephens AD, Alderman R, Chang D, et al. Morbidity and mortality of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the Coliseum technique. Ann Surg Oncol 1999;6(8):790-796 (Pubitemid 30013658)